Levebon

Levetiracetam, the active ingredient in Levebon, is a antiepileptic presented as an oral tablet for oral use. It treats partial‑onset seizures and generalized tonic‑clonic seizures in patients with epilepsy.

GNH USA supplies Levebon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levebon, an antiepileptic, is used to control seizure activity in epilepsy. - Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: may be used as adjunct therapy in certain patients.

Levebon may cause a range of adverse reactions.

Common Side Effects: - Dizziness: mild to moderate sensation of light‑headedness. - Fatigue: feeling unusually tired or weak. - Somnolence: increased sleepiness during the day. - Headache: mild to moderate head pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or feeling of queasiness.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hypersensitivity: rash, swelling, or anaphylaxis. - Depression: new or worsening depressive symptoms. - Suicidal thoughts: emergence of suicidal ideation. - Blood dyscrasias: anemia, leukopenia, or thrombocytopenia. - Severe rash: widespread erythema or blistering.

Before using Levebon, consider the following precautions. - Renal function: assess and adjust dose in patients with impaired kidney function. - Hepatic function: monitor liver enzymes in patients with liver disease. - Psychiatric symptoms: watch for mood changes, depression, or suicidal thoughts. - Pregnancy: discuss potential risks with the prescriber before use. - Concomitant CNS depressants: use caution when combined with other sedating agents. - Store at room temperature: keep in the original pack, protect from moisture and light.

Levebon can interact with several medications.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: can reduce levetiracetam effectiveness. - Phenytoin: may decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Acetaminophen: may increase levetiracetam levels. - Cimetidine: can raise levetiracetam concentrations. - Oral contraceptives: levetiracetam may reduce hormonal efficacy. - Antidepressants: monitor for enhanced mood changes.